• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

在共注射腺病毒载体和甘露醇后,β-己糖胺酶活性在桑德霍夫小鼠模型大脑中的广泛分布。

Widespread distribution of beta-hexosaminidase activity in the brain of a Sandhoff mouse model after coinjection of adenoviral vector and mannitol.

作者信息

Bourgoin C, Emiliani C, Kremer E J, Gelot A, Tancini B, Gravel R A, Drugan C, Orlacchio A, Poenaru L, Caillaud C

机构信息

Laboratoire de Génétique, Département Génétique, Développement et Pathologie Moléculaire, Institut Cochin, INSERM, CNRS, Paris V University, Paris, France.

出版信息

Gene Ther. 2003 Oct;10(21):1841-9. doi: 10.1038/sj.gt.3302081.

DOI:10.1038/sj.gt.3302081
PMID:12960974
Abstract

Sandhoff disease is a severe inherited neurodegenerative disorder resulting from deficiency of the beta-subunit of hexosaminidases A and B, lysosomal hydrolases involved in the degradation of G(M2) ganglioside and related metabolites. Currently, there is no viable treatment for the disease. Here, we show that adenovirus-mediated transfer of the beta-subunit of beta-hexosaminidase restored Hex A and Hex B activity after infection of Sandhoff fibroblasts. Gene transfer following intracerebral injection in a murine model of Sandhoff disease resulted in near-normal level of enzymatic activity in the entire brain at the different doses tested. The addition of hyperosmotic concentrations of mannitol to the adenoviral vector resulted in an enhancement of vector diffusion in the injected hemisphere. Adenoviral-induced lesions were found in brains injected with a high dose of the vector, but were not detected in brains injected with 100-fold lower doses, even in the presence of mannitol. Our data underline the advantage of the adjunction of mannitol to low doses of the adenoviral vector, allowing a high and diffuse transduction efficiency without viral cytotoxicity.

摘要

桑德霍夫病是一种严重的遗传性神经退行性疾病,由己糖胺酶A和B的β亚基缺乏引起,这两种溶酶体水解酶参与GM2神经节苷脂及相关代谢物的降解。目前,该疾病尚无有效的治疗方法。在此,我们表明腺病毒介导的β-己糖胺酶β亚基转移在感染桑德霍夫成纤维细胞后恢复了己糖胺酶A和己糖胺酶B的活性。在桑德霍夫病小鼠模型中进行脑内注射后,基因转移在测试的不同剂量下导致整个大脑的酶活性接近正常水平。向腺病毒载体中添加高渗浓度的甘露醇可增强载体在注射半球中的扩散。在注射高剂量载体的大脑中发现了腺病毒诱导的损伤,但在注射剂量低100倍的大脑中未检测到,即使存在甘露醇也是如此。我们的数据强调了将甘露醇添加到低剂量腺病毒载体中的优势,可实现高且弥散的转导效率而无病毒细胞毒性。

相似文献

1
Widespread distribution of beta-hexosaminidase activity in the brain of a Sandhoff mouse model after coinjection of adenoviral vector and mannitol.在共注射腺病毒载体和甘露醇后,β-己糖胺酶活性在桑德霍夫小鼠模型大脑中的广泛分布。
Gene Ther. 2003 Oct;10(21):1841-9. doi: 10.1038/sj.gt.3302081.
2
Reversion of the biochemical defects in murine embryonic Sandhoff neurons using a bicistronic lentiviral vector encoding hexosaminidase alpha and beta.使用编码己糖胺酶α和β的双顺反子慢病毒载体逆转小鼠胚胎桑德霍夫神经元中的生化缺陷。
J Neurochem. 2006 Mar;96(6):1572-9. doi: 10.1111/j.1471-4159.2006.03665.x. Epub 2006 Jan 25.
3
Bicistronic lentiviral vector corrects beta-hexosaminidase deficiency in transduced and cross-corrected human Sandhoff fibroblasts.双顺反子慢病毒载体可纠正转导及交叉校正的人类桑德霍夫病成纤维细胞中的β-己糖胺酶缺陷。
Neurobiol Dis. 2005 Nov;20(2):583-93. doi: 10.1016/j.nbd.2005.04.017. Epub 2005 Jun 13.
4
Induced secretion of beta-hexosaminidase by human brain endothelial cells: a novel approach in Sandhoff disease?人脑血管内皮细胞β-己糖胺酶的诱导分泌:桑格福德病的新方法?
Neurobiol Dis. 2010 Mar;37(3):656-60. doi: 10.1016/j.nbd.2009.12.001. Epub 2009 Dec 18.
5
Metabolic correction in microglia derived from Sandhoff disease model mice.源自桑德霍夫病模型小鼠的小胶质细胞中的代谢校正
J Neurochem. 2005 Sep;94(6):1631-8. doi: 10.1111/j.1471-4159.2005.03317.x. Epub 2005 Aug 10.
6
Restoration of hexosaminidase A activity in human Tay-Sachs fibroblasts via adenoviral vector-mediated gene transfer.通过腺病毒载体介导的基因转移恢复人类泰-萨克斯病成纤维细胞中的己糖胺酶A活性。
Gene Ther. 1996 Sep;3(9):769-74.
7
beta-hexosaminidase lentiviral vectors: transfer into the CNS via systemic administration.β-己糖胺酶慢病毒载体:通过全身给药导入中枢神经系统。
Brain Res Mol Brain Res. 2005 Feb 18;133(2):286-98. doi: 10.1016/j.molbrainres.2004.10.026.
8
Specific induction of macrophage inflammatory protein 1-alpha in glial cells of Sandhoff disease model mice associated with accumulation of N-acetylhexosaminyl glycoconjugates.桑德霍夫病模型小鼠神经胶质细胞中巨噬细胞炎性蛋白1-α的特异性诱导与N-乙酰己糖胺糖缀合物的积累有关。
J Neurochem. 2005 Mar;92(6):1497-507. doi: 10.1111/j.1471-4159.2005.02986.x.
9
Systemic hyperosmolality improves beta-glucuronidase distribution and pathology in murine MPS VII brain following intraventricular gene transfer.全身高渗状态可改善脑室注射基因转移后小鼠黏多糖贮积症VII型脑中β-葡萄糖醛酸酶的分布及病理状况。
Exp Neurol. 1999 Nov;160(1):109-16. doi: 10.1006/exnr.1999.7205.
10
Mouse models of Tay-Sachs and Sandhoff diseases differ in neurologic phenotype and ganglioside metabolism.泰-萨克斯病和桑德霍夫病的小鼠模型在神经表型和神经节苷脂代谢方面存在差异。
Nat Genet. 1995 Oct;11(2):170-6. doi: 10.1038/ng1095-170.

引用本文的文献

1
Therapeutic genetic restoration through allogeneic brain microglia replacement.通过同种异体脑小胶质细胞替代实现治疗性基因修复。
Nature. 2025 Aug 6. doi: 10.1038/s41586-025-09461-6.
2
Targeting Neurological Aspects of Mucopolysaccharidosis Type II: Enzyme Replacement Therapy and Beyond.靶向黏多糖贮积症 II 型的神经学方面:酶替代疗法及其他。
BioDrugs. 2024 Sep;38(5):639-655. doi: 10.1007/s40259-024-00675-0. Epub 2024 Aug 23.
3
Targeting the central nervous system in lysosomal storage diseases: Strategies to deliver therapeutics across the blood-brain barrier.
靶向溶酶体贮积症的中枢神经系统:血脑屏障穿越的治疗策略。
Mol Ther. 2023 Mar 1;31(3):657-675. doi: 10.1016/j.ymthe.2022.11.015. Epub 2022 Nov 30.
4
Advances in Optical Sensors of -Acetyl-β-d-hexosaminidase (-Acetyl-β-d-glucosaminidase).β-己糖苷酶(β-葡糖苷酶)光学传感器的研究进展。
Bioconjug Chem. 2022 Apr 20;33(4):544-554. doi: 10.1021/acs.bioconjchem.2c00057. Epub 2022 Mar 18.
5
White Matter Pathology as a Barrier to Gangliosidosis Gene Therapy.白质病理学作为神经节苷脂贮积症基因治疗的障碍
Front Cell Neurosci. 2021 Aug 12;15:682106. doi: 10.3389/fncel.2021.682106. eCollection 2021.
6
Biocompatible Polymer Nanoparticles for Drug Delivery Applications in Cancer and Neurodegenerative Disorder Therapies.用于癌症和神经退行性疾病治疗中药物递送应用的生物相容性聚合物纳米颗粒
J Funct Biomater. 2019 Jan 8;10(1):4. doi: 10.3390/jfb10010004.
7
Efficacy of a Bicistronic Vector for Correction of Sandhoff Disease in a Mouse Model.双顺反子载体对小鼠模型中桑德霍夫病的矫正效果
Mol Ther Methods Clin Dev. 2018 Oct 26;12:47-57. doi: 10.1016/j.omtm.2018.10.011. eCollection 2019 Mar 15.
8
Animal models of GM2 gangliosidosis: utility and limitations.GM2神经节苷脂沉积症的动物模型:效用与局限性。
Appl Clin Genet. 2016 Jul 20;9:111-20. doi: 10.2147/TACG.S85354. eCollection 2016.
9
Novel Vector Design and Hexosaminidase Variant Enabling Self-Complementary Adeno-Associated Virus for the Treatment of Tay-Sachs Disease.新型载体设计与己糖胺酶变体助力自互补腺相关病毒治疗泰-萨克斯病
Hum Gene Ther. 2016 Jul;27(7):509-21. doi: 10.1089/hum.2016.013.
10
Gangliosides and gangliosidoses: principles of molecular and metabolic pathogenesis.神经节苷脂与神经节苷脂贮积症:分子与代谢发病机制原理。
J Neurosci. 2013 Jun 19;33(25):10195-208. doi: 10.1523/JNEUROSCI.0822-13.2013.